Singer Raye wins Mercury Prize for 'This Music May Contain Hope'

2 weeks ago

LONDON, Oct 22 (Reuters) - Singer Raye won the Mercury Prize for her second studio album "This Music May Contain…

Japan's Hashimoto bags fourth consecutive all-around title

2 weeks ago

VIDEO SHOWS: 2026 WORLD ARTISTIC GYMNASTICS CHAMPIONSHIPS MEN'S ALL-AROUND FINAL HIGHLIGHTS COMPLETE SHOTLIST & SCRIPT TO FOLLOW SHOWS: ROTTERDAM, NETHERLANDS…

FCC grants Intel waiver for foreign-made robotic devices

2 weeks ago

By David Shepardson WASHINGTON, Oct 22 (Reuters) - The Federal Communications Commission said on Thursday it has granted a waiver…

FCC grants Intel waiver for foreign-made robotic devices

2 weeks ago

By David Shepardson WASHINGTON, Oct 22 (Reuters) - The Federal Communications Commission said on Thursday it has granted a waiver…

UPDATE 1-Venezuelans call for elections in first national protest in nearly two years

2 weeks ago

* Protests take place in Caracas, Valencia, Maracay, San Cristobal and Maracaibo * Ruling party holds overlapping Caracas march, prompting…

Japan's Hashimoto bags fourth consecutive all-around title

2 weeks ago

VIDEO SHOWS: 2026 WORLD ARTISTIC GYMNASTICS CHAMPIONSHIPS MEN'S ALL-AROUND FINAL HIGHLIGHTS COMPLETE SHOTLIST & SCRIPT TO FOLLOW SHOWS: ROTTERDAM, NETHERLANDS…

BRIEF-Rio Tinto To Invest $1.9 Billion To Develop The Kangwinan Bauxite Project In Western Cape York, Queensland

2 weeks ago

Oct 22 (Reuters) - Rio Tinto Limited: * RIO TINTO TO INVEST $1.9 BILLION TO DEVELOP THE KANGWINAN BAUXITE PROJECT…

Exclusive-Australian agency mulled firing KPMG over data-handling rule breach, documents show

2 weeks ago

SYDNEY, Oct 23 (Reuters) - KPMG Australia breached a contract with the country's biggest federal agency by transferring sensitive government…

SK Hynix drops US IPO plan for Solidigm, newspaper reports

2 weeks ago

SEOUL, Oct 23 (Reuters) - South Korean chipmaker SK Hynix has decided not to pursue a US initial public offering…

BRIEF-Huyabio International Announces Hbi-8000 And Nivolumab Combination Reduces The Risk Of Disease Progression By 27% In Patients With Advanced Melanoma In Phase 3 Trial

2 weeks ago

Oct 22 (Reuters) - * HUYABIO INTERNATIONAL ANNOUNCES HBI-8000 AND NIVOLUMAB COMBINATION REDUCES THE RISK OF DISEASE PROGRESSION BY 27%…